Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway

Total flavonoids of Rhizoma drynariae (TFRD), a Chinese medicine, is widely used in the treatment of fracture, bone defect, osteoporosis and other orthopedic diseases, and has achieved good effects. Purpose of this trial was to explore efficacy of TFRD on bone graft’s mineralization and osteoblasts’...

Full description

Bibliographic Details
Main Authors: Shuyuan Li, Hongliang Zhou, Cheng Hu, Jiabao Yang, Jinfei Ye, Yuexi Zhou, Zige Li, Leilei Chen, Qishi Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.675470/full
id doaj-a33224c82e0b4d40b7f4a648043487b1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Shuyuan Li
Shuyuan Li
Hongliang Zhou
Hongliang Zhou
Cheng Hu
Cheng Hu
Jiabao Yang
Jiabao Yang
Jinfei Ye
Jinfei Ye
Yuexi Zhou
Yuexi Zhou
Zige Li
Zige Li
Leilei Chen
Qishi Zhou
spellingShingle Shuyuan Li
Shuyuan Li
Hongliang Zhou
Hongliang Zhou
Cheng Hu
Cheng Hu
Jiabao Yang
Jiabao Yang
Jinfei Ye
Jinfei Ye
Yuexi Zhou
Yuexi Zhou
Zige Li
Zige Li
Leilei Chen
Qishi Zhou
Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
Frontiers in Pharmacology
total flavonoids of rhizoma drynariae
induced membrane
Wnt/β-catenin
bone defect
osteogenic efficacy
author_facet Shuyuan Li
Shuyuan Li
Hongliang Zhou
Hongliang Zhou
Cheng Hu
Cheng Hu
Jiabao Yang
Jiabao Yang
Jinfei Ye
Jinfei Ye
Yuexi Zhou
Yuexi Zhou
Zige Li
Zige Li
Leilei Chen
Qishi Zhou
author_sort Shuyuan Li
title Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
title_short Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
title_full Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
title_fullStr Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
title_full_unstemmed Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling Pathway
title_sort total flavonoids of rhizoma drynariae promotes differentiation of osteoblasts and growth of bone graft in induced membrane partly by activating wnt/β-catenin signaling pathway
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-05-01
description Total flavonoids of Rhizoma drynariae (TFRD), a Chinese medicine, is widely used in the treatment of fracture, bone defect, osteoporosis and other orthopedic diseases, and has achieved good effects. Purpose of this trial was to explore efficacy of TFRD on bone graft’s mineralization and osteoblasts’ differentiation in Masquelet induced membrane technique in rats. Forty male Sprague-Dawley rats were randomly divided into high dose group (H-TFRD), middle dose group (M-TFRD), low dose group (L-TFRD) and control group (control). The critical size bone defect model of rats was established with 10 rats in each group. Polymethyl methacrylate (PMMA) spacer was implanted into the defect of right femur in rats. After the formation of the induced membrane, autogenous bone was implanted into the induced membrane. After 12 weeks of bone graft, bone tissues in the area of bone graft were examined by X-ray, Micro-CT, hematoxylin-eosin (HE) and Masson trichrome staining to evaluate the growth of the bone graft. The β-catenin, c-myc, COL1A1, BMP-2 and OPN in bone graft were quantitatively analyzed by Western blot and Immunohistostaining. Osteoblasts were cultured in the medium containing TFRD. Cell Counting Kit-8 (CCK-8) method, Alkaline phosphatase (ALP) and Alizarin Red S (ARS) staining, Western blot, RT-PCR and other methods were used to detect the effects of TFRD on the proliferation of osteoblasts and the regulation of Wnt/β-catenin signaling pathway. In vivo experiments showed that the growth and mineralization of bone graft in TFRD group was better. Moreover, the expression of Wnt/β-catenin and osteogenesis-related proteins in bone tissue of TFRD group was more than that in other groups. In vitro experiments indicated that osteoblasts proliferated faster, activity of ALP was higher, number of mineralized nodules and proteins related to osteogenesis were more in TFRD group. But blocking Wnt/β-catenin signaling pathway could limit these effects. Therefore, TFRD could promote mineralization of bone graft and differentiation of osteoblasts in a dose-dependent manner during growing period of the bone graft of induced membrane technique, which is partly related to the activation of Wnt/β-catenin signaling pathway.
topic total flavonoids of rhizoma drynariae
induced membrane
Wnt/β-catenin
bone defect
osteogenic efficacy
url https://www.frontiersin.org/articles/10.3389/fphar.2021.675470/full
work_keys_str_mv AT shuyuanli totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT shuyuanli totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT hongliangzhou totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT hongliangzhou totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT chenghu totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT chenghu totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT jiabaoyang totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT jiabaoyang totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT jinfeiye totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT jinfeiye totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT yuexizhou totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT yuexizhou totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT zigeli totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT zigeli totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT leileichen totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
AT qishizhou totalflavonoidsofrhizomadrynariaepromotesdifferentiationofosteoblastsandgrowthofbonegraftininducedmembranepartlybyactivatingwntbcateninsignalingpathway
_version_ 1721302378278289408
spelling doaj-a33224c82e0b4d40b7f4a648043487b12021-07-14T20:37:52ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-05-011210.3389/fphar.2021.675470675470Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling PathwayShuyuan Li0Shuyuan Li1Hongliang Zhou2Hongliang Zhou3Cheng Hu4Cheng Hu5Jiabao Yang6Jiabao Yang7Jinfei Ye8Jinfei Ye9Yuexi Zhou10Yuexi Zhou11Zige Li12Zige Li13Leilei Chen14Qishi Zhou15Guangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaGuangzhou University of Chinese Medicine, Guangzhou, ChinaLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou, ChinaThird Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, ChinaFirst Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, ChinaTotal flavonoids of Rhizoma drynariae (TFRD), a Chinese medicine, is widely used in the treatment of fracture, bone defect, osteoporosis and other orthopedic diseases, and has achieved good effects. Purpose of this trial was to explore efficacy of TFRD on bone graft’s mineralization and osteoblasts’ differentiation in Masquelet induced membrane technique in rats. Forty male Sprague-Dawley rats were randomly divided into high dose group (H-TFRD), middle dose group (M-TFRD), low dose group (L-TFRD) and control group (control). The critical size bone defect model of rats was established with 10 rats in each group. Polymethyl methacrylate (PMMA) spacer was implanted into the defect of right femur in rats. After the formation of the induced membrane, autogenous bone was implanted into the induced membrane. After 12 weeks of bone graft, bone tissues in the area of bone graft were examined by X-ray, Micro-CT, hematoxylin-eosin (HE) and Masson trichrome staining to evaluate the growth of the bone graft. The β-catenin, c-myc, COL1A1, BMP-2 and OPN in bone graft were quantitatively analyzed by Western blot and Immunohistostaining. Osteoblasts were cultured in the medium containing TFRD. Cell Counting Kit-8 (CCK-8) method, Alkaline phosphatase (ALP) and Alizarin Red S (ARS) staining, Western blot, RT-PCR and other methods were used to detect the effects of TFRD on the proliferation of osteoblasts and the regulation of Wnt/β-catenin signaling pathway. In vivo experiments showed that the growth and mineralization of bone graft in TFRD group was better. Moreover, the expression of Wnt/β-catenin and osteogenesis-related proteins in bone tissue of TFRD group was more than that in other groups. In vitro experiments indicated that osteoblasts proliferated faster, activity of ALP was higher, number of mineralized nodules and proteins related to osteogenesis were more in TFRD group. But blocking Wnt/β-catenin signaling pathway could limit these effects. Therefore, TFRD could promote mineralization of bone graft and differentiation of osteoblasts in a dose-dependent manner during growing period of the bone graft of induced membrane technique, which is partly related to the activation of Wnt/β-catenin signaling pathway.https://www.frontiersin.org/articles/10.3389/fphar.2021.675470/fulltotal flavonoids of rhizoma drynariaeinduced membraneWnt/β-cateninbone defectosteogenic efficacy